[Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000378:metabolism; D024841:Fluoroquinolones; D006801:Humans; D010787:Photosensitivity Disorders / Q000139:chemically induced; D015363:Quinolones / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000378:metabolism
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C061363:sparfloxacin